CYTK vs. SPY
Compare and contrast key facts about Cytokinetics, Incorporated (CYTK) and State Street SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Performance
CYTK vs. SPY - Performance Comparison
Loading graphics...
CYTK vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CYTK Cytokinetics, Incorporated | 3.73% | 35.08% | -43.66% | 82.21% | 0.53% | 119.35% | 95.85% | 67.88% | -22.45% | -32.92% |
SPY State Street SPDR S&P 500 ETF | -4.37% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Returns By Period
In the year-to-date period, CYTK achieves a 3.73% return, which is significantly higher than SPY's -4.37% return. Over the past 10 years, CYTK has outperformed SPY with an annualized return of 24.80%, while SPY has yielded a comparatively lower 13.98% annualized return.
CYTK
- 1D
- 4.67%
- 1M
- 5.93%
- YTD
- 3.73%
- 6M
- 19.92%
- 1Y
- 64.00%
- 3Y*
- 23.27%
- 5Y*
- 21.95%
- 10Y*
- 24.80%
SPY
- 1D
- 2.91%
- 1M
- -4.94%
- YTD
- -4.37%
- 6M
- -1.82%
- 1Y
- 17.59%
- 3Y*
- 18.19%
- 5Y*
- 11.69%
- 10Y*
- 13.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CYTK vs. SPY — Risk / Return Rank
CYTK
SPY
CYTK vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CYTK | SPY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.03 | 0.93 | +0.10 |
Sortino ratioReturn per unit of downside risk | 2.01 | 1.45 | +0.55 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.22 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.73 | 1.53 | +0.20 |
Martin ratioReturn relative to average drawdown | 4.05 | 7.30 | -3.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CYTK | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.03 | 0.93 | +0.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.69 | -0.37 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.78 | -0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.02 | 0.56 | -0.59 |
Correlation
The correlation between CYTK and SPY is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CYTK vs. SPY - Dividend Comparison
CYTK has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.14%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CYTK Cytokinetics, Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.14% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Drawdowns
CYTK vs. SPY - Drawdown Comparison
The maximum CYTK drawdown since its inception was -97.09%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for CYTK and SPY.
Loading graphics...
Drawdown Indicators
| CYTK | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.09% | -55.19% | -41.90% |
Max Drawdown (1Y)Largest decline over 1 year | -30.48% | -12.05% | -18.43% |
Max Drawdown (5Y)Largest decline over 5 years | -72.39% | -24.50% | -47.89% |
Max Drawdown (10Y)Largest decline over 10 years | -72.39% | -33.72% | -38.67% |
Current DrawdownCurrent decline from peak | -39.01% | -6.24% | -32.77% |
Average DrawdownAverage peak-to-trough decline | -76.38% | -9.09% | -67.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.98% | 2.52% | +10.46% |
Volatility
CYTK vs. SPY - Volatility Comparison
Cytokinetics, Incorporated (CYTK) has a higher volatility of 11.45% compared to State Street SPDR S&P 500 ETF (SPY) at 5.31%. This indicates that CYTK's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CYTK | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.45% | 5.31% | +6.14% |
Volatility (6M)Calculated over the trailing 6-month period | 30.77% | 9.47% | +21.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 63.06% | 19.05% | +44.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.94% | 17.06% | +52.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.85% | 17.92% | +49.93% |